chr16-3590273-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_032444.4(SLX4):​c.3365C>T​(p.Pro1122Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.109 in 1,613,854 control chromosomes in the GnomAD database, including 15,972 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P1122A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.20 ( 5242 hom., cov: 32)
Exomes 𝑓: 0.10 ( 10730 hom. )

Consequence

SLX4
NM_032444.4 missense

Scores

1
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 0.123

Publications

46 publications found
Variant links:
Genes affected
SLX4 (HGNC:23845): (SLX4 structure-specific endonuclease subunit) This gene encodes a protein that functions as an assembly component of multiple structure-specific endonucleases. These endonuclease complexes are required for repair of specific types of DNA lesions and critical for cellular responses to replication fork failure. Mutations in this gene were found in patients with Fanconi anemia. [provided by RefSeq, Sep 2016]
SLX4 Gene-Disease associations (from GenCC):
  • Fanconi anemia complementation group P
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • familial ovarian cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=2.5084615E-4).
BP6
Variant 16-3590273-G-A is Benign according to our data. Variant chr16-3590273-G-A is described in ClinVar as Benign. ClinVar VariationId is 262047.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.466 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_032444.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLX4
NM_032444.4
MANE Select
c.3365C>Tp.Pro1122Leu
missense
Exon 12 of 15NP_115820.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLX4
ENST00000294008.4
TSL:5 MANE Select
c.3365C>Tp.Pro1122Leu
missense
Exon 12 of 15ENSP00000294008.3

Frequencies

GnomAD3 genomes
AF:
0.200
AC:
30309
AN:
151868
Hom.:
5215
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.470
Gnomad AMI
AF:
0.111
Gnomad AMR
AF:
0.146
Gnomad ASJ
AF:
0.0597
Gnomad EAS
AF:
0.0865
Gnomad SAS
AF:
0.185
Gnomad FIN
AF:
0.100
Gnomad MID
AF:
0.114
Gnomad NFE
AF:
0.0815
Gnomad OTH
AF:
0.178
GnomAD2 exomes
AF:
0.125
AC:
31500
AN:
251384
AF XY:
0.121
show subpopulations
Gnomad AFR exome
AF:
0.481
Gnomad AMR exome
AF:
0.111
Gnomad ASJ exome
AF:
0.0556
Gnomad EAS exome
AF:
0.0883
Gnomad FIN exome
AF:
0.103
Gnomad NFE exome
AF:
0.0822
Gnomad OTH exome
AF:
0.0984
GnomAD4 exome
AF:
0.0999
AC:
146005
AN:
1461868
Hom.:
10730
Cov.:
38
AF XY:
0.101
AC XY:
73266
AN XY:
727234
show subpopulations
African (AFR)
AF:
0.500
AC:
16755
AN:
33480
American (AMR)
AF:
0.110
AC:
4903
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0550
AC:
1438
AN:
26136
East Asian (EAS)
AF:
0.0905
AC:
3593
AN:
39700
South Asian (SAS)
AF:
0.180
AC:
15562
AN:
86258
European-Finnish (FIN)
AF:
0.0967
AC:
5162
AN:
53398
Middle Eastern (MID)
AF:
0.124
AC:
714
AN:
5768
European-Non Finnish (NFE)
AF:
0.0815
AC:
90664
AN:
1112008
Other (OTH)
AF:
0.119
AC:
7214
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
8931
17861
26792
35722
44653
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3608
7216
10824
14432
18040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.200
AC:
30379
AN:
151986
Hom.:
5242
Cov.:
32
AF XY:
0.200
AC XY:
14831
AN XY:
74314
show subpopulations
African (AFR)
AF:
0.471
AC:
19514
AN:
41426
American (AMR)
AF:
0.145
AC:
2223
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.0597
AC:
207
AN:
3470
East Asian (EAS)
AF:
0.0867
AC:
446
AN:
5142
South Asian (SAS)
AF:
0.185
AC:
889
AN:
4816
European-Finnish (FIN)
AF:
0.100
AC:
1059
AN:
10572
Middle Eastern (MID)
AF:
0.112
AC:
33
AN:
294
European-Non Finnish (NFE)
AF:
0.0815
AC:
5537
AN:
67962
Other (OTH)
AF:
0.175
AC:
370
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1004
2007
3011
4014
5018
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
286
572
858
1144
1430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.125
Hom.:
7167
Bravo
AF:
0.215
TwinsUK
AF:
0.0787
AC:
292
ALSPAC
AF:
0.0786
AC:
303
ESP6500AA
AF:
0.461
AC:
2027
ESP6500EA
AF:
0.0841
AC:
723
ExAC
AF:
0.135
AC:
16360
Asia WGS
AF:
0.175
AC:
610
AN:
3478
EpiCase
AF:
0.0804
EpiControl
AF:
0.0819

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Fanconi anemia complementation group P Benign:4
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Nov 27, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Aug 18, 2017
IntelligeneCG
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

not specified Benign:2
Aug 31, 2012
Leiden Open Variation Database
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:curation

Curator: Arleen D. Auerbach. Submitter to LOVD: Janine Bakker.

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Feb 25, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Fanconi anemia Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.077
BayesDel_addAF
Benign
-0.84
T
BayesDel_noAF
Benign
-0.83
CADD
Benign
8.2
DANN
Benign
0.20
DEOGEN2
Benign
0.24
T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.077
N
LIST_S2
Benign
0.22
T
MetaRNN
Benign
0.00025
T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
-0.14
N
PhyloP100
0.12
PrimateAI
Benign
0.25
T
PROVEAN
Uncertain
-2.8
D
REVEL
Benign
0.028
Sift
Benign
0.82
T
Sift4G
Benign
0.23
T
Polyphen
0.0030
B
Vest4
0.013
MPC
0.057
ClinPred
0.0068
T
GERP RS
-0.66
Varity_R
0.038
gMVP
0.11
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs714181; hg19: chr16-3640274; COSMIC: COSV53561011; API